The diagnostic accuracy of urine-derived exosomes for bladder cancer: a systematic review and meta-analysis

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2024;74(3):229–63.

PubMed  Google Scholar 

Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82–104.

Article  PubMed  CAS  Google Scholar 

Zhao M, He XL, Teng XD. Understanding the molecular pathogenesis and prognostics of bladder cancer: an overview. Chin J Cancer Res = Chung-kuo yen cheng yen chiu. 2016;28(1):92–8.

PubMed  CAS  Google Scholar 

Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15(1):25–41.

Article  PubMed  CAS  Google Scholar 

Jocham D, Stepp H, Waidelich R. Photodynamic diagnosis in urology: state-of-the-art. Eur Urol. 2008;53(6):1138–48.

Article  PubMed  CAS  Google Scholar 

Burke DM, Shackley DC, O’Reilly PH. The community-based morbidity of flexible cystoscopy. BJU Int. 2002;89(4):347–9.

Article  PubMed  CAS  Google Scholar 

Johnson MI, Merrilees D, Robson WA, Lennon T, Masters J, Orr KE, et al. Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy. BJU Int. 2007;100(4):826–9.

Article  PubMed  CAS  Google Scholar 

Sun S, Lee D, Ho AS, Pu JK, Zhang XQ, Lee NP, et al. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways. Neuro Oncol. 2013;15(5):562–77.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhu Z, He A, Lv T, Xu C, Lin L, Lin J. Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma. Cancer Biomarkers. 2019;26(4):431–9.

Article  PubMed  CAS  Google Scholar 

Fu L, Zhang J, Li L, Yang Y, Yuan Y. Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: a meta-analysis of diagnostic test accuracy in head-to-head studies. Oncol Lett. 2020;19(2):1165–74.

PubMed  CAS  Google Scholar 

Bhat A, Ritch CR. Urinary biomarkers in bladder cancer: where do we stand? Curr Opin Urol. 2019;29(3):203–9.

Article  PubMed  Google Scholar 

Tan WS, Tan WP, Tan MY, Khetrapal P, Dong L, deWinter P, et al. Novel urinary biomarkers for the detection of bladder cancer: A systematic review. Cancer Treat Rev. 2018;69:39–52.

Article  PubMed  CAS  Google Scholar 

Laukhtina E, Shim SR, Mori K, D’Andrea D, Soria F, Rajwa P, et al. Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis. Eur Urol Oncol. 2021;4(6):927–42.

Article  PubMed  Google Scholar 

Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of Exosome Composition. Cell. 2019;177(2):428–45.e18.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. https://doi.org/10.1126/science.aau6977.

Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–83.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015;8:83.

Article  PubMed  PubMed Central  Google Scholar 

Kalluri R. The biology and function of exosomes in cancer. J Clin Investig. 2016;126(4):1208–15.

Article  PubMed  PubMed Central  Google Scholar 

Beckham CJ, Olsen J, Yin PN, Wu CH, Ting HJ, Hagen FK, et al. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. J Urol. 2014;192(2):583–92.

Article  PubMed  CAS  Google Scholar 

McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018;319(4):388–96.

Article  PubMed  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clin Research ed). 2003;327(7414):557–60.

Article  Google Scholar 

Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882–93.

Article  PubMed  Google Scholar 

Abbastabar M, Sarfi M, Golestani A, Karimi A, Pourmand G, Khalili E. Tumor-derived urinary exosomal long non-coding rnas as diagnostic biomarkers for bladder cancer. EXCLI J. 2020;19:301–10.

PubMed  PubMed Central  Google Scholar 

Bian B, Li L, Ke X, Chen H, Liu Y, Zheng N, et al. Urinary exosomal long non-coding RNAs as noninvasive biomarkers for diagnosis of bladder cancer by RNA sequencing. Front Oncol. 2022;12:976329.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen C, Shang A, Sun Z, Gao Y, Huang J, Ping Y, et al. Urinary exosomal long noncoding RNA TERC as a noninvasive diagnostic and prognostic biomarker for bladder urothelial carcinoma. J Immunol Res. 2022;2022:9038808.

Article  PubMed  PubMed Central  Google Scholar 

El-Shal AS, Shalaby SM, Abouhashem SE, Elbary EHA, Azazy S, Rashad NM, et al. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer. Mol Biol Rep. 2021;48(5):4361–71.

Article  PubMed  CAS  Google Scholar 

Güllü Amuran G, Tinay I, Filinte D, Ilgin C, Peker Eyüboğlu I, Akkiprik M. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls. Int Urol Nephrol. 2020;52(3):461–8.

Article  PubMed  Google Scholar 

Huang H, Du J, Jin B, Pang L, Duan N, Huang C, et al. Combination of urine exosomal mRNAs and lncRNAs as novel diagnostic biomarkers for bladder cancer. Front Oncol. 2021;11:667212.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lee JS, Park HS, Han SR, Kang YH, Mun JY, Shin DW, et al. Alpha-2-macroglobulin as a novel diagnostic biomarker for human bladder cancer in urinary extracellular vesicles. Front Oncol. 2022;12:976407.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lin H, Shi X, Li H, Hui J, Liu R, Chen Z, et al. Urinary exosomal miRNAs as biomarkers of bladder cancer and experimental verification of mechanism of miR-93-5p in bladder cancer. BMC Cancer. 2021;21(1):1293.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu C, Xu P, Shao S, Wang F, Zheng Z, Li S, et al. The value of urinary exosomal lncRNA SNHG16 as a diagnostic biomarker for bladder cancer. Mol Biol Rep. 2023;50(10):8297–304.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Matsuzaki K, Fujita K, Jingushi K, Kawashima A, Ujike T, Nagahara A, et al. MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma. Oncotarget. 2017;8(15):24668–78.

Article  PubMed  PubMed Central 

留言 (0)

沒有登入
gif